GNC sales increase
This article was originally published in The Tan Sheet
General Nutrition Centers sales advanced 6.7 percent in 2008 to $1.66 billion, the Pittsburgh-based nutritional supplements retailer announces March 19. Earnings before income taxes, depreciation and amortization for the year were $212.2 million, compared to $125.5 million in 2007, when the firm absorbed a number of costs associated with the 2007 acquisition of the firm's parent company (1"The Tan Sheet" Feb. 12, 2007, p. 9). In the fourth quarter, consolidated revenues increased 4.2 percent to $391.7 million, with growth recorded in each of the firm's business segments. Fourth quarter EBITDA was relatively flat at $45.8 million, the firm says
You may also be interested in...
Ares Management and the Ontario Teachers' Pension Plan private investment groups have agreed to purchase the parent company of vitamin and nutritional supplement firm GNC for $1.65 billion, the firms announce Feb. 9
The number of new drugs containing new active substances approved in the EU rose significantly in 2020, underpinned by a strong showing for orphan-designated products and a string of novel medicines for cancer and infectious diseases. Notable among the new clutch of approvals was the first ever COVID-19 vaccine, Pfizer/BioNTech's Comirnaty.
The Canadian medtech regulator has recommended updating its list of recognized medical device standards that manufacturers can rely on to demonstrate compliance with local safety, effectiveness and labeling requirements.